Investigating the biomedical applications of gold - Introduction

Transition metals have been widely used in medicine throughout history. The medicinal use of metals extends back to the earliest recorded history when the Chinese used gold as treatment for a variety of ailments. The ancient Egyptians used copper to sterilize water and mercury was reportedly used by Hippocrates in 400BC. Thereafter, numerous other metals have been used as treatment throughout the centuries. For example, zinc sulphate was used as an emetic in the 17th century and zinc oxide was used to treat epilepsy in the 18th century. This use of metals, and numerous other instances, which have been well described in Sneader 2008,1 make for interesting reading but largely occurred prior to the advent of rigorous scientific method. Therefore, although there are exemptions, most therapeutic applications of metals prior to the modern age lack scientific grounding and have been found to be mostly ineffective. Of more relevance are metal-based medicines approved by regulatory bodies (i.e. Food and Drug Administration; FDA) that are in current use as therapeutic drugs. There are presently a large number of metal-based drugs that are approved for use by the FDA ranging from over the counter medicines, such as bismuth subsalicylate for gastrointestinal problems, to prescription drugs such as lithium carbonate for the treatment of manic depression. The list of metal-based medicines approved by the FDA not only incorporates base metals but also includes precious metals. Platinum complexes have been found to be potently active against several different types of cancers while gold complexes have shown application as treatment for rheumatoid arthritis (RA). With the well-established foundation that exists for metal-based medicines, it is imperative to continue exploration into new therapeutic areas. The precious metals; gold, ruthenium and platinum, continue to attract scientific interest in the field of biomedicine and have been widely researched. Scientific studies conducted on gold complexes have demonstrated the potential of this metal for the treatment of HIV/AIDS, cancer and malaria. These diseases are also specific health concerns for developing nations; countries where disease has devastating impact. Within South Africa alone, an estimated 5.7 million people are infected with HIV/AIDS,2 approximately 7 000 new cases of malaria are reported annually, and it is projected that 1 in 4 persons will develop cancer. Continuous development of therapeutic drugs to combat these diseases is therefore apriority, and the exploration of gold-based compounds for this purpose is warranted.